FTC studying legality of authorized generics deals
August 11th 2008A pending Federal Trade Commission (FTC) report, expected later this year, may settle the decade-old dispute as to whether authorized generics are legal. With billions of dollars at stake, the loser will undoubtedly challenge the government's decision.
Four-dollar pricing considered boon and bust
August 11th 2008Are $4 generics the future of pharmacy? Perhaps so, as the consumption of generic drugs soars and their costs drop. Wal-Mart, which beat a thorny path to what many pharmacists believe is loss-leader pricing, says $4 was a great move. It is very popular-and good for business.
Profitable foot care category grows steadily
August 11th 2008Consumers have never had more choices when it comes to treating their tootsies. Today's foot-care category boasts a solid mix of products designed to treat corns, calluses, bunions, warts, odor, wetness, and fungus. Also lining the foot-care shelves are orthotics, insoles, and inserts, along with popular foot grooming items.
Added to platinum-based chemotherapy, cetuximab improves lung cancer survival
August 11th 2008Of more than 4,000 cancer studies presented at the recent annual meeting of the American Society of Clinical Oncology, those exploring effects of targeted therapy cetuximab combined with platinum-based chemotherapy generated the most buzz.